Horizon Kinetics Medical ETF Rating $29.40 -0.42 (-1.41%) Closing price 09/12/2025 02:58 PM EasternExtended Trading$29.40 0.00 (0.00%) As of 09/12/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.65Holdings in MEDX have an aggregate rating of Moderate Buy based on 349 analyst ratings issued in the past year covering 23 companies (81.5% of the portfolio).MEDX Aggregate Price Target$29.40High Prediction$29.40Average Prediction$29.40Low Prediction$29.40Holdings in MEDX have an aggregate price target of $29.40 and a range of $29.40 to $29.40 covering 23 companies (81.5% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.30%LLYEli Lilly and Company$754.90-0.2%4.9979 of 5 stars2.68$941.35 24.7%22Trending News9.42%ABBVAbbVie$218.40-0.8%4.7803 of 5 stars2.92$217.10 -0.6%26Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision6.42%ALNYAlnylam Pharmaceuticals$465.89-0.6%3.7898 of 5 stars2.85$421.28 -9.6%27Positive NewsAnalyst ForecastInsider Trade5.33%AZNAstraZeneca$79.56-1.9%2.8138 of 5 stars2.75$86.00 8.1%4Trending NewsShort Interest ↑Analyst Revision4.95%JNJJohnson & Johnson$178.10-0.2%4.6908 of 5 stars2.65$176.29 -1.0%20Trending NewsAnalyst UpgradeAnalyst Revision4.60%BMYBristol Myers Squibb$46.22-2.8%4.8679 of 5 stars2.24$56.38 22.0%21News CoveragePositive News4.15%IONSIonis Pharmaceuticals$63.16-1.4%3.6813 of 5 stars2.81$67.88 7.5%16Insider Trade3.92%AMGNAmgen$276.39-2.2%4.6437 of 5 stars2.32$304.43 10.1%22Positive News3.92%ALKSAlkermes$26.97-2.7%4.5571 of 5 stars2.92$41.85 55.2%13Trending NewsAnalyst Forecast3.75%PFEPfizer$23.91-3.8%4.9875 of 5 stars2.39$28.12 17.6%18Trending NewsHigh Trading Volume3.32%MRKMerck & Co., Inc.$82.87-2.7%4.9965 of 5 stars2.35$107.44 29.6%20Positive News3.22%CRSPCRISPR Therapeutics$56.26+0.7%3.2872 of 5 stars2.47$71.60 27.3%17News Coverage2.54%GSKGSK$40.81-1.6%2.0353 of 5 stars1.86$37.38 -8.4%7Positive NewsDividend Cut2.52%BIIBBiogen$144.86-2.7%4.7588 of 5 stars2.32$181.65 25.4%31Positive News2.41%REGNRegeneron Pharmaceuticals$560.00-1.4%4.7671 of 5 stars2.82$817.67 46.0%28Positive NewsShort Interest ↑1.38%GALTGalectin Therapeutics$5.37-9.6%1.3312 of 5 stars3.00$6.00 11.7%1Positive NewsGap UpHigh Trading Volume0.95%NTLAIntellia Therapeutics$11.424.3911 of 5 stars2.56$27.11 137.4%18Analyst Revision0.91%BEAMBeam Therapeutics$20.60-4.4%2.8529 of 5 stars3.08$46.40 125.2%130.80%HLNHaleon$9.81-0.7%4.1158 of 5 stars2.80$12.33 25.7%10Positive NewsAnalyst UpgradeShort Interest ↓0.71%VNDAVanda Pharmaceuticals$4.51-2.0%4.1818 of 5 stars3.50$16.50 265.9%2Positive News0.68%SDZNYSandoz Group$59.90-1.0%1.8801 of 5 stars2.003News CoverageShort Interest ↓0.67%LTRNLantern Pharma$3.83-2.5%2.5962 of 5 stars3.00$25.00 552.7%1Positive News0.60%BCYCBicycle Therapeutics$7.07+0.7%3.6352 of 5 stars2.67$22.22 214.3%9Positive News This page (NASDAQ:MEDX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
